Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 12:56 AM
NCT ID:
NCT00865293
Eligibility Criteria:
Inclusion Criteria obese population:
* Male/female, age 25-60
* BMI (body mass index) 30-40 kg/m2
* Non or ex smokers with \< 10 packyears
Inclusion Criteria control population:
* Male/female, age 25-60
* BMI (body mass index) 18.5-25 kg/m2
* Non or ex smokers with \<10 packyears
Exclusion Criteria obese population:
* Asthma
* COPD (FEV1/FVC\<0.70)
* Reversibility \>9% in FEV1 (400 microgram salbutamol)
* Other significant neuromuscular, cardiac or lung disease
Exclusion Criteria control population:
* Asthma
* COPD (FEV1/FVC\<0.70)
* Other significant neuromuscular, cardiac or lung disease
* Reversibility \>9% in FEV1 (400 microgram salbutamol)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
60 Years
Study:
NCT00865293
Study Brief:
Protocol Section:
NCT00865293